Novavax: Lobbying Update: $50,000 of NOVAVAX INC. lobbying was just disclosed
$50,000 of NOVAVAX INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
Read full article »
Novavax is a Maryland-based biotechnology company that researches, develops and commercializes vaccines for the treatment of infectious diseases.
Read more